You are viewing the site in preview mode
Skip to main content
|
Variables
|
MIPD (N = 26)
|
OPD (N = 119)
|
P-value
|
|---|
|
Age (years)
|
71.03 ± 8.8
|
64.40 ± 11.70
|
0.008
|
|
Male (Male)
|
16 (61.5%)
|
70 (58.8%)
|
0.490
|
|
ASA (n, %)
| | |
0.895
|
|
I
|
0 (0%)
|
1 (0.8%)
| |
|
II
|
10 (38.5%)
|
46 (38.7%)
| |
|
III
|
16 (61.5%)
|
72 (60.5%)
| |
|
ECOG (n, %)
| | |
0.003
|
|
0
|
19 (73.1%)
|
112 (94.1%)
| |
|
1
|
5 (19.2%)
|
6 (5.0%)
| |
|
2
|
2 (7.7%)
|
1 (0.8%)
| |
|
Pathology (n, %)
| | |
0.036
|
|
Benign
|
1 (3.8%)
|
9 (7.6%)
| |
|
Ampullary cancer
|
13 (50.0%)
|
25 (21.0%)
| |
|
CBD cancer
|
4 (15.4%)
|
17 (19.3%)
| |
|
PDAC
|
5 (19.2%)
|
40 (42.0%)
| |
|
IPMN
|
2 (7.7%)
|
3 (2.5%)
| |
|
PNET
|
0 (0%)
|
6 (5.0%)
| |
|
Duodenal cancer
|
1 (3.8%)
|
3 (2.5%)
| |
|
Tumor size (cm ± SD)
|
2.68 ± 1.80
|
3.14 ± 1.33
|
0.231
|
|
Lymph node harvest (number ± SD)
|
14.23 ± 8.04
|
19.83 ± 9.71
|
0.004
|
|
Pre-op bile drain (n, %)
|
14 (53.8%)
|
70 (58.8%)
|
0.400
|
|
Abdominal surgery history (n, %)
|
5 (19.2%)
|
25 (21.0%)
|
0.539
|
|
Hypertension (n, %)
|
14 (53.8%)
|
50 (42.0%)
|
0.189
|
|
DM (n, %)
|
8 (30.8%)
|
26 (21.8%)
|
0.232
|
|
CAD (n, %)
|
1 (3.8%)
|
15 (12.6)
|
0.174
|
|
COPD (n, %)
|
1 (3.8%)
|
2 (1.7%)
|
0.450
|
|
CKD (n, %)
|
1 (3.8%)
|
10 (8.4%)
|
0.378
|
|
CCI (n, %)
| | |
0.062
|
|
0
|
8 (30.8%)
|
63 (52.9%)
| |
|
1
|
10 (38.5%)
|
36 (30.3%)
| |
|
2
|
7 (26.9)
|
16 (13.4%)
| |
|
3
|
0 (0%)
|
3 (2.5%)
| |
|
4
|
0 (0%)
|
1 (0.8)
| |
|
5
|
1
|
0 (0%)
| |
- Italic indicate statistic significance
- MIPD minimal invasive pancreatoduodenectomy, OPD open pancreatoduodenectomy, ASA score American Society of Anesthesiologists classification score, ECOG Eastern Cooperative Oncology Group, CBD Common bile duct, PDAC pancreatic ductal adenocarcinoma, IPMN intraductal papillary mucinous neoplasm, PNET pancreatic neuroendocrine tumor, DM Diabetes Mellitus, CKD chronic kidney disease, CCI Charlson comorbidity index
